Codivir

N/A

Report date: 2025/05/09 15:53:51
NME

Base Information

Drug NameCodivir
Drug Alias NameGammora
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionVirus internalization inhibitors
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)HIV SeropositivityHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe Hebrew University Of Jerusalem
China Registration ClassN/A

Develop Information

Active CompaniesFederal University Of Sao PauloCode Pharma
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)HIV SeropositivityHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A